XCSEBACTIQ
Market cap11mUSD
Dec 23, Last price
3.60DKK
1D
7.78%
1Q
-45.04%
IPO
-81.50%
Name
Bactiquant A/S
Chart & Performance
P/E
—
P/S
6.88
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
2.24%
Rev. gr., 5y
17.86%
Revenues
12m
-0.69%
Net income
-13m
L-7.62%
CFO
-8m
L-52.27%
Earnings
Apr 17, 2025
Profile
Bactiquant A/S develops and provides technology for the mobile and online surveillance of bacterial contamination levels in water. It offers Mobile Lab, a handheld tool for pollution tracking; and an online solution to quantify the bacteria in water systems. It serves various industries in the areas of aquaculture, data centers, oil and gas, water utility, industry, and pharma. The company is based in 1999 and is based in Horsholm, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 12,303 -0.69% | 12,389 48.20% | 8,359 52.48% | |||
Cost of revenue | 13,059 | 14,877 | 12,186 | |||
Unusual Expense (Income) | ||||||
NOPBT | (756) | (2,488) | (3,827) | |||
NOPBT Margin | ||||||
Operating Taxes | 193 | 119 | ||||
Tax Rate | ||||||
NOPAT | (756) | (2,681) | (3,946) | |||
Net income | (13,104) -7.62% | (14,185) 4.66% | (13,552) 1,280.49% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 13,690 | 7,372 | 25,649 | |||
BB yield | -27.68% | -5.62% | -14.65% | |||
| Debt | ||||||
Debt current | 1,166 | 509 | ||||
Long-term debt | 8,437 | 9,429 | 2,087 | |||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | (3,387) | 6,969 | (7,852) | |||
| Cash flow | ||||||
Cash from operating activities | (8,159) | (17,095) | (13,249) | |||
CAPEX | (541) | (757) | (2,194) | |||
Cash from investing activities | (582) | (768) | (2,590) | |||
Cash from financing activities | 16,946 | 11,040 | 25,613 | |||
FCF | 4,420 | (7,212) | (6,912) | |||
| Balance | ||||||
Cash | 11,824 | 3,619 | 10,442 | |||
Long term investments | 7 | 7 | ||||
Excess cash | 11,209 | 3,006 | 10,031 | |||
Stockholders' equity | 12,736 | 14,307 | 21,063 | |||
Invested Capital | 11,640 | 17,181 | 12,585 | |||
ROIC | 0.47% | |||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 20,604 | 19,708 | 19,028 | |||
Price | 2.40 -63.96% | 6.66 -27.61% | 9.20 | |||
Market cap | 49,449 -62.33% | 131,253 -25.02% | 175,054 | |||
EV | 46,062 | 138,222 | 167,202 | |||
EBITDA | 639 | (763) | (3,559) | |||
EV/EBITDA | 72.05 | |||||
Interest | 1,522 | 701 | 827 | |||
Interest/NOPBT | ||||||